New developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension delivery technology

D'Urzo, AD; Cazzola, M; Hanania, NA; Buhl, R; Maleki-Yazdi, MR

D'Urzo, AD (reprint author), Univ Toronto, Dept Family & Community Med, Fac Med, 500 Univ Ave,5th Floor, Toronto, ON M5G 1V7, Canada.

INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018; 13 (): 2805

Abstract

COPD causes considerable health and economic burden worldwide, with incidence of the disease expected to continue to rise. Inhaled bronchodilators, su......

Full Text Link